Overview

Docetaxel and S-1 for Advanced Esophageal Cancer

Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of docetaxel and S-1 combination chemotherapy in Korean patients with esophageal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Hallym University Medical Center
Collaborator:
Jeil Pharmaceutical Co., Ltd.
Treatments:
Docetaxel